Validation in diabetic rats of a fully automated insulin delivery system based on impulsive offset-free MPC control
Open Access
- 4 September 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (9) , e0330121
Abstract
The development of an impulsive automated insulin delivery system (i-AiDS) for type 1 diabetes mellitus aims to provide real-time blood glucose regulation with minimal human intervention. This study presents the validation of an offset-free impulsive zone model predictive control strategy designed to cope with external disturbances such as meal intake and plant-model mismatch in a diabetic rat model. Fourteen male Wistar rats induced diabetes with streptozotocin were monitored using an continuous glucose monitoring and regulated by delivering insulin with a customized low-cost pump. After acquiring diabetes condition, the procedure for installing the devices in the rat is carried out. During the first day, manual insulin injections are made by the pump, the glucose response is recorded by the interface and an off-line parametric estimation is executed. Based on the parameters found, simulations are used for the first tuning of the controller and the estimator. During the second day, the parameters of the model and the control are tested and adjusted. Finally, on the third day, a 72-hour test of the impulsive begins in full autonomous mode. Results showed that the controller achieved an average of 83.4% of the time within the target range of 80-180 mg/dL, with no severe hypoglycemic or hyperglycemic events. The median absolute relative difference between model predictions and actual sensor data was 24.66%, indicating the presence of plant-model mismatch that was effectively handled by the controller. Peak hyperglycemic events reached 320 mg/dL, but were regulated within 50 minutes, while mild hypoglycemic events occurred in 3.62 ± 1.8 cases per subject. The study demonstrates the efficacy of the controller in managing unannounced carbohydrate intake and physiological disturbances in a real-world preclinical environment. These findings provide a foundation for future clinical trials, emphasizing the importance of in vivo validation of control strategies to refine the i-AiDS for human use. Improvements in model accuracy and dynamic parameter tuning could further enhance performance, particularly in longer experimental periods.Keywords
Funding Information
- Universidad Nacional de Colombia (61299)
This publication has 34 references indexed in Scilit:
- A comprehensive review of models and nonlinear control strategies for blood glucose regulation in artificial pancreasAnnual Reviews in Control, 2024
- Do sex differences in paediatric type 1 diabetes care exist? A systematic reviewDiabetologia, 2023
- Advanced hybrid artificial pancreas system improves on unannounced meal response - In silico comparison to currently available systemComputer Methods and Programs in Biomedicine, 2021
- Stable impulsive zone model predictive control for type 1 diabetic patients based on a long‐term modelOptimal Control Applications and Methods, 2020
- A critical review and analysis of ethical issues associated with the artificial pancreasDiabetes & Metabolism, 2019
- Neural network-based model predictive control for type 1 diabetic rats on artificial pancreas systemMedical & Biological Engineering & Computing, 2018
- A Review of Safety and Design Requirements of the Artificial PancreasAnnals of Biomedical Engineering, 2016
- Linear offset-free Model Predictive ControlAutomatica, 2009
- Induction of diabetes by Streptozotocin in ratsIndian Journal of Clinical Biochemistry, 2007
- A numerically stable dual method for solving strictly convex quadratic programsMathematical Programming, 1983